Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD”
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Hansel (London, United Kingdom). Translating mechanisms to new drugs for COPD exacerbations. Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD”

Member's Comments

No comment yet.

Related content which might interest you: Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology Source: ERS Satellites 2021 Year: 2021 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Aetiology of exacerbations of asthma and COPD: new viruses, new mechanisms Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010 Prevention of COPD exacerbations: medications and other controversies Source: ERJ Open Res 2015; 1: 00011-2015 Year: 2015 Challenges in COPD exacerbations and future research and unknowns Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention Year: 2013 Mechanisms and management of COPD exacerbations caused by respiratory mechanisms Source: Annual Congress 2013 –MS1 Differential diagnosis and management of exacerbations of respiratory symptoms in elderly patients with COPD Year: 2013 Recommendations for pharmacological treatment of exacerbations of COPD Source: International Congress 2017 – Treatment and prevention of COPD exacerbation Year: 2017 Therapeutic options for COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 Mechanisms and management of COPD exacerbations caused by non-respiratory mechanisms Source: Annual Congress 2013 –MS1 Differential diagnosis and management of exacerbations of respiratory symptoms in elderly patients with COPD Year: 2013 The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Pharmacological strategies for self-management of asthma exacerbations Source: Eur Respir J 2006; 28: 182-199 Year: 2006 Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD Source: International Congress 2017 – Treatment and prevention of COPD exacerbation Year: 2017 Linking phenotypes to personalised treatments in asthma and COPD Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations Source: Eur Respir Rev 2006; 15: 47-51 Year: 2006 Macrolides in the prevention of COPD exacerbations Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012 Antibiotics in COPD exacerbations: practice and evidence Source: Breathe 2009; 5: 299-301 Year: 2009 The investigation of infectious agents and their antibiotic sensitivities in COPD exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006